Publications

Search our bibliography using the filters on the right-hand side.

Displaying 51 through 100 of 138 publications.

Meyers JL, Madhwani S, Rausch D, Candrilli SD, Krishnarajah G, Yan S. Analysis of real-world health care costs among immunocompetent patients aged 50 years or older with herpes zoster in the United States. Hum Vaccin Immunother. 2017 Aug 3;13(8):1861-72.

Rausch DA, Levin M, Meyers J, Candrilli S, Yan S, Krishnarajah G, Patterson B. Cost of diagnosed herpes zoster complications in patients age ≥50 years: a US claims data analysis. Poster presented at the IAGG 2017 World Congress; July 23, 2017. San Francisco, CA. [abstract] Innov Aging. 2017 Jul; 1(Suppl 1):902. doi: 10.1093/geroni/igx004.3234

Buck PO, Meyers JL, Gordon LD, Parikh R, Kurosky SK, Davis KL. Economic burden of diagnosed pertussis among individuals with asthma or chronic obstructive pulmonary disease in the USA: an analysis of administrative claims. Epidemiol Infect. 2017 Jul;145(10):2109-21. doi: 10.1017/S0950268817000887.

Blonde L, Lew E, Raccah D, Meyers J, Ajmera M, Davis K, Bertolini M, Guerci B. Impact of time to basal insulin initiation on glycemic control and health care costs in T2DM patients: an analysis of US commercial claims data. Poster presented at the American Diabetes Association 77th Scientific Sessions; June 10, 2017. San Diego, CA.

Blonde L, Lew E, Raccah D, Meyers J, Ajmera M, Davis K, Bertolini M, Guerci B. A real-world comparison of outcomes in patients receiving three oral antidiabetic therapies, GLP-1, or basal insulin: an analysis of electronic medical record data. Poster presented at the American Diabetes Association 77th Scientific Sessions; June 10, 2017. San Diego, CA.

Bell K, Meyers J, Candrilli SD, Ajmera MR. Characteristics and costs of patients with type 2 diabetes augmenting metformin with dapagliflozin versus glipizide: an analysis of commercial claims data. Poster presented at the 2017 ISPOR 22nd Annual International Meeting; May 23, 2017. Boston, MA. [abstract] Value Health. 2017 May; 20(5):A169.

Nagar SP, Fox KM, Rane PP, Beaubrun A, Qian Y, Inomata H, Davis KL, Meyers J, Kajinami K. Incidence of cardiovascular events among secondary prevention patients treated with statins or ezetimibe in Japan. Poster presented at the 2017 ISPOR 22nd Annual International Meeting; May 23, 2017. Boston, MA. [abstract] Value Health. 2017 May; 20(5):A261.

Kajinami K, Nagar SP, Meyers J, Rane PP, Davis K, Fox KM, Beaubrun A, Inomata H, Qian Y. Treatment utilization patterns and possible statin intolerance among high-risk patients in a real-world Japanese population. Poster presented at the 81st Annual Scientific Meeting of the Japanese Circulation Society; March 19, 2017. Kanazawa, Japan.

Meyers J, Gajria K, Candrilli SD, Fridman M, Sikirica V. The impact of adjunctive guanfacine extended release on stimulant adherence in children/adolescents with attention-deficit/hyperactivity disorder. J Comp Eff Res. 2017 Mar;6(2):109-25. doi: 10.2217/cer-2016-0039

Dhamane AD, Ajmera M, Meyers J, Davis KL. Treatment interruption patterns among adalimumab users in a commercially insured managed care population. Poster presented at the 2017 AMCP Managed Care & Specialty Pharmacy Annual Meeting; March 2017. Denver, CO. [abstract] J Manag Care Spec Pharm. 2017 Mar; 23(3a):S98.

Raccah D, Lew E, Guerci B, Meyers JL, Ajmera M, Davis KL, Bertolini M, Blonde L. Impact of time to basal insulin initiation on glycaemic control in type 2 diabetes mellitus patients: an electronic medical record database analysis. Poster presented at the 52nd EASD Annual Meeting 2016; September 2016. Munich, Germany.

Blonde L, Kitio-Dschassi B, Guerci B, Meyers J, Berria R, Ajmera M, Nikonova E, Davis K, Bertolini M, Raccah D. A real-world comparison of longitudinal HbA1c and health care costs in patients receiving two oral antidiabetic therapies, GLP-1RAs, or basal insulin. Presented at the 76th American Diabetes Association (ADA) Scientifc Sessions; June 13, 2016. New Orleans, LA.

Blonde L, Kitio-Dschassi B, Guerci B, Meyers J, Berria R, Ajmera M, Nikonova E, Davis K, Bertolini M, Raccah D. A real-world comparison of outcomes in patients receiving two oral antidiabetic therapies, GLP-1RAs, or basal insulin: an analysis of electronic medical record data. Poster presented at the 76th American Diabetes Association (ADA) Scientifc Sessions; June 12, 2016. New Orleans, LA.

Meyers J, Chaudhari P, Madhwani S, Candrilli SD. Clinical and economic burden of peripheral artery disease among patients receiving endovascular interventions: a retrospective cohort study of commercially insured patients in the United States. Poster presented at the 2016 ISPOR 21st Annual International Meeting; May 23, 2016. Washington, DC. [abstract] Value Health. 2016 May; 19(3):A45.

Dhamane A, Candrilli S, Meyers J, Luthra R, Kaila S. Initial diagnosis and treatment patterns by healthcare setting among chronic obstructive pulmonary disease (COPD) patients in the United States. Poster presented at the 2016 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 2016. San Francisco, CA. [abstract] J Manag Care Pharm. 2016 Apr; 22(4-a):S90.

Buck PO, Gordon LD, Meyers J, Parikh R, Kurosky S, Davis KL. Economic burden of diagnosed pertussis among individuals with asthma or chronic obstructive pulmonary disease: a US database study. Poster presented at the National Foundation for Infectious Diseases 19th Annual Conference on Vaccine Research; April 2016. Bethesda, MD.

Davis KL, Meyers J, Zhao Z, McCollam PL, Murakami M. High-risk atherosclerotic cardiovascular disease in a real-world employed Japanese population: prevalence, cardiovascular event rates, and costs. J Atheroscler Thromb. 2015 Dec 1;22(12):1287-304. doi: 10.5551/jat.28852

Candrilli SD, Dhamane AD, Meyers JL, Kaila S. Factors associated with inpatient readmission among managed care enrollees with COPD. Hospital Practice. 2015 Oct;43(4):199-207. doi: 10.1080/21548331.2015.1085797

Meyers J, Grebla R, Ajmera M, Davis K, Pawaskar M. Comorbidity burden in delayed and nondelayed ADHD diagnosis among commercially insured adults in the United States. Poster presented at the 28th Annual US Psychiatric and Mental Health Congress; September 10, 2015. San Diego, CA.

Yan S, Meyers J, Candrilli SD, Rausch D, Madhwani S, Krishnarajah G. A real-world health care cost analysis for immunocompetent herpes zoster patients greater than or equal to 50 years old, using an employer-based database in the United States. Presented at the 2015 Interscience Conference of Antimicrobial Agents and Chemotherapy; September 2015. San Diego, CA.

Candrilli SD, Meyers JL, Boye K, Bae JP. Health care resource utilization and costs during episodes of care for type 2 diabetes mellitus-related comorbidities. J Diabetes Complications. 2015 May;29(4):529-33. doi: 10.1016/j.jdiacomp.2014.12.009

Meyers JL, Candrilli SD. Common reasons for and associated burden of inpatient admissions among children in the United States. Poster presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA. [abstract] Value Health. 2015 May; 18(3):A252-3.

Wang T, Meyers J, Davis K, Madhwani S, Boklage S. Patterns of H. pylori treatment and testing for patients in a commercially insured population. Poster presented at the 2015 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 1, 2015. San Diego, CA. [abstract] J Manag Care Pharm. 2015 Apr; 21(4-a):S11.

Davis KL, Wei W, Meyers JL, Kilpatrick BS, Pandya N. Use of basal insulin and the associated clinical outcomes among elderly nursing home residents with type 2 diabetes mellitus: a retrospective chart review study. Clin Interv Aging. 2014 Oct 23;2014(9):1815-22. doi: 10.2147/CIA.S65411

Davis KL, Wei W, Meyers JL, Kilpatrick BS, Pandya N. Association between different hemoglobin a1c levels and clinical outcomes among elderly nursing home residents with type 2 diabetes mellitus. J Am Med Dir Assoc. 2014 Oct;15(10):757-962. doi: 10.1016/j.jamda.2014.06.007

Bae JP, Candrilli SD, Fortenberry J, Meyers JL, Jakubowski JA, Drenning D. Point-of-care platelet reactivity determination with VerifyNow-P2Y12® following administration of clopidogrel or prasugrel: data from a real-world, clinical-care inpatient setting. Hospital Practice. 2014 Oct;42(4):7-15. doi: 10.3810/hp.2014.10.1139

Yu Y, Meyers JL, Kaila S, Dhamane A, Candrilli SD. Assessment of spirometry testing and inpatient readmission in patients with chronic obstructive pulmonary disease. Poster presented at the 2014 ISPOR 19th Annual International Meeting; June 3, 2014.

Blonde L, Brunton S, Chava B, Zhou R, Davis KL, Meyers JL, Dalal M, Digenio A. Achievement of goal A1C (less than 7%) by US patients with T2DM on basal insulin in both randomized controlled trials (RCTS) and in clinical practice. Poster presented at the American Diabetes Association; June 2014. San Francisco, CA.

Meyers JL, Yu Y, Kaila S, Dhamane A, Candrilli SD. Factors associated with chronic obstructive pulmonary disease-related inpatient readmissions. Poster presented at the 2014 ISPOR 19th Annual International Meeting; May 2014.

Meyers JL, Parasuraman S, Bell K, Graham JP, Candrilli SD. The high-cost, type 2 diabetes mellitus patient: an analysis of managed care administrative data. Arch Public Health. 2014 Feb 27;72(1):6.

Pandya N, Wei W, Meyers J, Kilpatrick B, Davis K. Burden of sliding scale insulin use in elderly long-term care residents with type 2 diabetes mellitus. J Am Geriatr Soc. 2013 Dec;61(12):2103-10. doi: 10.1111/jgs.12547.

Davis KL, Tangirala M, Meyers JL, Wei W. Real-World Comparative Outcomes of US Type 2 Diabetes Patients Initiating Analog Basal Insulin Therapy. Curr Med Res Opin. 2013 Aug 1;29(9):1083-91.

Cohen CJ, Meyers JL, Davis KL. Association between daily antiretroviral pill burden and treatment adherence, hospitalisation risk, and other healthcare utilisation and costs in a US medicaid population with HIV. BMJ Open. 2013 Aug 1;3(8):e003028.

Meyers J, Yu Y, Kaye JA, Davis KL. Medicare fee-for-service enrollees with primary acute myeloid leukemia: an analysis of treatment patterns, survival, and healthcare resource utilization and costs. Appl Health Econ Health Policy. 2013 May 16;11(3):275-86. doi: 10.1007/s40258-013-0032-2

Davis KL, Fitzgerald TP, Meyers J, Kulkarni A, Svarvar P, Hewitt DJ. Economic burden of adverse treatment effects in parkinson's disease: evidence from a large employer population. Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 2013. New Orleans, LA. [abstract] Value Health. 2013 May; 16(3):A103-4.

Davis KL, Fitzgerald T, Meyers J, Kulkarni A, Svarvar P, Hewitt D. Incidence of adverse treatment effects in parkinson's disease: evidence from a large employer population. Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 15, 2013. [abstract] Value Health. 2013 May; 16(3):A100.

Davis KL, Fitzgerald T, Kulkarni A, Meyers J, Svarvar P, Hewitt D. Comparative risk of adverse treatment effects in parkinson's disease: evidence from a large employer population. Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 15, 2013. [abstract] Value Health. 2013 May; 16(3):A100.

Zhao Z, McCollam PL, Davis KL, Meyers JL, Murakami M. Statin adherence and persistence among Japanese patients with high risk vascular disease: a Japan claims database analysis. Poster presented at the American Heart Association Quality of Care and Outcomes Research Meeting; May 2013.

Davis KL, Meyers J, Zhao Z, McCollam P, Murakami M. High-risk vascular disease in Japan: evidence on incidence and prevalence, patient characteristics, and treatment rates from a large Japanese claims database. Poster presented at the 2013 ISPOR 18th Annual International Meeting; April 23, 2013. [abstract] Value Health. 2013 Apr; 16(3):A277.

Cohen C, Davis KL, Meyers JL. Association of partial adherence (PA) to antiretroviral therapy with hospitalizations and healthcare costs in an HIV population. Poster presented at the 11th International Congress on Drug Therapy in HIV Infection; November 2012.

Mersey J, Wei W, Meyers J, Wang CC, Dalal MR, Bromberger LA, Levin P. Real-world treatment patterns and outcomes when initiating once-daily injectable pen therapy with insulin glargine or liraglutide - an electronic medical records study. Poster presented at the 2012 ISPOR 15th Annual European Congress; November 2012. Berlin, Germany. [abstract] Value Health. 2012 Nov; 15(7):A494. doi: 10.1016/j.jval.2012.08.1648

Davis KL, Tangiral K, Meyers JL, Wei W. Real-world comparative outcomes of US type 2 diabetes patients initiating analog basal insulin therapy. Poster presented at the 48th Annual Meeting of the European Association for the Study of Diabetes; October 2012.

Meyers J, Candrilli S, Allen R, Manjunath R, Calloway M. Health care resource utilization and costs associated with restless legs syndrome among managed care enrollees treated with dopamine agonists. Manag Care. 2012 Oct 1;21(10):44-51.

Dalal M, Ling Z, Davis KL, Meyers JL, Digenio A. Real-world characteristics of patients with type 2 diabetes on basal insulin initiating add-on GLP-1 analog therapy. Poster presented at the 48th Annual Meeting of the European Association for the Study of Diabetes; October 2012.

Digenio A, Ling Z, Davis KL, Meyers JL, Dalal M. Real-world characteristics of patients with type 2 diabetes initiating insulin glargine plus liraglutide or insulin glargine plus exenatide. Poster presented at the 48th Annual Meeting of the European Association for the Study of Diabetes; October 2012.

Davis KL, Wei W, Meyers JL, Kilpatrick B, Pandya N. Are clinical outcomes associated with different A1C levels in elderly patients? Poster presented at the 72nd Scientific Sessions of the American Diabetes Association; June 2012.

Meyers J, Yu Y, Davis KL. Patient survival, health care utilization, and costs in Medicare patients with acute myeloid leukemia compared to matched controls. Poster presented at the 2012 ISPOR 17th Annual International Meeting; June 1, 2012. Washington, DC. [abstract] Value Health. 2012 Jun; 15(4):A214.

Davis KL, Wei W, Kilpatrick BS, Meyers JL, Pandya N. Use of basal insulins in elderly nursing home residents with type 2 diabetes mellitus: a retrospective chart review study. Poster presented at the Annual Scientific Meeting of the American Geriatric Society; May 2012.

Candrilli SD, Bae JP, Fortenberry J, Meyers JL, Jakubowski JA, Drenning D. Point-of-care platelet reactivity determination with VerifyNow-P2Y12® following administration of clopidogrel or prasugrel: data from a real-world clinical care setting. Poster presented at the Society for Cardiovascular Angiography and Interventions 2012 Scientific Sessions; May 2012.

Davis KL, Wei W, Meyers J, Kilpatrick BS, Pandya N. A retrospective study of basal insulin analogs in elderly nursing home residents with type-2 diabetes. Poster presented at the 2012 American Geriatrics Society Annual Scientific Meeting; April 2012. [abstract] J Am Geriatr Soc. 2012 Apr; 60(S4):S51.